What's new

Filters: reports
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs

30 October 2023

Report

Read More

A Strong European API Industry Can Achieve Strategic Autonomy of the EU Health System

9 November 2022

Report

Read More

New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe

30 June 2022

Report

  New pricing models for generic medicines to ensure long-term […]

Read more

Removing access barriers in Central and Eastern Europe – April 2022

25 April 2022

Report

Read More

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

30 September 2021

Report

Read More

Market Review – European Generic Medicine Markets 2020

1 March 2021

Report

Read More

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Read More

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Read More

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]